234
Feohifomikoz Etkenleri

1. Arcobello JT, Revankar SG. Phaeohyphomycosis. Semin Respir Crit Care Med 2020; 41: 131–140.
2. Schieffelin JS, Garcia-Diaz JB, Loss GE, Jr., et al. Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment. Transpl Infect Dis
2014; 16: 270–278.
3. Thomas E, Bertolotti A, Barreau A, et al. From phaeohyphomycosis to disseminated chromoblastomycosis: A retrospective study of infections caused by dematiaceous fungi. Med Mal Infect
2018; 48: 278–285.
4. Chowdhary A, Meis JF, Guarro J, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. Clin
Microbiol Infect 2014; 20 Suppl 3: 47–75.
5. Prenafeta-Boldu FX, Summerbell R, Sybren de Hoog G. Fungi growing on aromatic hydrocarbons: biotechnology’s unexpected encounter with biohazard? FEMS Microbiol Rev 2006; 30:
109–130.
6. Revankar SG, Sutton DA. Melanized fungi in human disease. Clin Microbiol Rev 2010; 23: 884–928.
7. Costa FF, Souza RSC, Voidaleski MF, et al. Sugarcane: an unexpected habitat for black yeasts in Chaetothyriales. IMA Fungus 2023; 14: 20.
8. Chowdhary A, Perfect J, de Hoog GS. Black molds and melanized yeasts pathogenic to humans. Cold Spring Harb Perspect Med 2014; 5: a019570.
9. Kantarcioglu AS, Guarro J, De Hoog S, et al. An updated comprehensive systematic review of Cladophialophora bantiana and analysis of epidemiology, clinical characteristics, and outcome
of cerebral cases. Med Mycol 2017; 55: 579–604.
10. Velasco J, Revankar S. CNS infections caused by brown-black fungi. J Fungi (Basel) 2019; 5.
11. Malani AN, Singal B, Wheat LJ, et al. (1,3)-beta-d-glucan in cerebrospinal fluid for diagnosis of fungal meningitis associated with contaminated methylprednisolone injections. J Clin Micro-
biol 2015; 53: 799–803.
12. Koo S, Klompas M, Marty FM. Fonsecaea monophora cerebral phaeohyphomycosis: case report of successful surgical excision and voriconazole treatment and review. Med Mycol 2010; 48:
769–774.
13. Ala-Houhala M, Koukila-Kahkola P, Antikainen J, et al. Clinical use of fungal PCR from deep tissue samples in the diagnosis of invasive fungal diseases: a retrospective observational study.
Clin Microbiol Infect 2018; 24: 301–305.
14. Abliz P, Fukushima K, Takizawa K, et al. Identification of pathogenic dematiaceous fungi and related taxa based on large subunit ribosomal DNA D1/D2 domain sequence analysis. FEMS
Immunol Med Microbiol 2004; 40: 41–49.
15. Wang X, Zhang R, Wu W, et al. Impaired specific antifungal immunity in CARD9-deficient patients with phaeohyphomycosis. J Invest Dermatol 2018; 138: 607–617.
16. McCarty TP, Baddley JW, Walsh TJ, et al. Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET). Med Mycol 2015;
53: 440–446.
17. He Y, Zheng HL, Mei H, et al. Phaeohyphomycosis in China. Front Cell Infect Microbiol 2022; 12: 895329.
18. Ben-Ami R, Lewis RE, Raad, II, et al. Phaeohyphomycosis in a tertiary care cancer center. Clin Infect Dis 2009; 48: 1033–1041.
19. Revankar SG. Phaeohyphomycosis in transplant patients. J Fungi (Basel) 2015; 2.
20. Tsang CC, Chan KF, Chan W, et al. Hepatic phaeohyphomycosis due to a novel dematiaceous fungus, Pleurostoma hongkongense sp. nov., and importance of antifungal susceptibility testing.
Emerg Microbes Infect 2021; 10: 81–96.
21. Astolfo MF, Canazares P, Majek E, et al. Invasive acute sinusitis by Exserohilum rostratum in a patient with medullary relapse of acute lymphoblastic leukemia. Arch Argent Pediatr 2018; 116:
e594–e598.
22. Thomas D, Johnson J, Bittar HT, et al. An uncommon case of fungal rhinosinusitis caused by the mold Exserohilum rostratum in a patient with relapsed acute myeloid leukemia: Case report
and review of the literature. Ann Clin Lab Sci 2023; 53: 964–968.
23. Derber C, Elam K, Bearman G. Invasive sinonasal disease due to dematiaceous fungi in immunocompromised individuals: case report and review of the literature. Int J Infect Dis 2010; 14:
E329–E332.
24. Kohashi S, Toyama T, Hashimoto N, et al. Sinusitis caused by Exserohilum rostratum after cord blood transplantation for myelodysplastic syndrome: A case report and literature review. Transpl
Infect Dis 2018; 20.
25. Tauziede-Espariat A, Wassef M, Adle-Biassette H, et al. Sinonasal fungal infections are not exclusively due to mucorales and Aspergillus!. Ann Pathol 2016; 36: 245–251.
26. Maurya AK, Kumari S, Behera G, et al. Rhino sinusitis caused by Lasiodiplodia theobromae in a diabetic patient. Med Mycol Case Rep 2023; 40: 22–24.
27. Pal D, Noronha AK, Bandyopadhyay R, et al. Cladophialophora bantiana – A rare cause of soil-transmitted fungal brain abscess in tropical countries. IDCases 2023; 34: e01909.
28. Gamaletsou MN, Rammaert B, Brause B, et al. Osteoarticular mycoses. Clin Microbiol Rev 2022; 35: e0008619.
29. Prasad S, Khurana U, Karuna T, et al. Fine needle aspiration of nodular cystic swelling showing a rare melanized fungus Medicopsis romeroi: A case report. Diagn Cytopathol 2020; 48: 401–404.
30. Taj-Aldeen SJ, Rammaert B, Gamaletsou M, et al. Osteoarticular infections caused by non-Aspergillus filamentous fungi in adult and pediatric patients: A systematic review. Medicine (Balti-
more) 2015; 94: e2078.
31. Smith RM, Schaefer MK, Kainer MA, et al. Fungal infections associated with contaminated methylprednisolone injections. N Engl J Med 2013; 369: 1598–1609.
32. Maraki S, Katzilakis N, Neonakis I, et al. Exophiala dermatitidis central line-associated bloodstream infection in a child with Ewing’s sarcoma: Case report and literature review on paediatric
infections. Mycopathologia 2022; 187: 595–602.
33. Verdecia J, Jankowski CA, Reynolds ML, et al. Fungemia due to Aureobasidium pullulans. Med Mycol Case Rep 2022; 37: 26–28.
34. Dogra M, Dhingra D, Sharma SP, et al. A rare case of Lecythophora endogenous endophthalmitis: Diagnostic and therapeutic challenge. Indian J Ophthalmol 2018; 66: 1203–1205.
35. Fox AR, Houser KH, Morris WR, et al. Dematiaceous fungal endophthalmitis: report of a case and review of the literature. J Ophthalmic Inflamm Infect 2016; 6: 43.
36. Alex D, Li D, Calderone R, et al. Identification of Curvularia lunata by polymerase chain reaction in a case of fungal endophthalmitis. Med Mycol Case Rep 2013; 2: 137–140.
37. Revankar SG, Patterson JE, Sutton DA, et al. Disseminated phaeohyphomycosis: review of an emerging mycosis. Clin Infect Dis 2002; 34: 467–476.
38. Chen SC, Blyth CC, Sorrell TC, et al. Pneumonia and lung infections due to emerging and unusual fungal pathogens. Semin Respir Crit Care Med 2011; 32: 703–716.
39. Shoham S, Pic-Aluas L, Taylor J, et al. Transplant-associated Ochroconis gallopava infections. Transpl Infect Dis 2008; 10: 442–448.
40. Geltner C, Sorschag S, Willinger B, et al. Necrotizing mycosis due to Verruconis gallopava in an immunocompetent patient. Infection 2015; 43: 743–746.
41. Latawa A, Panda I, Kaur H, et al. Cerebral phaeohyphomycosis: The ‘Dark Side’ of fungal infections. Clin Neurol Neurosurg 2022; 214: 107173.
42. Revankar SG, Sutton DA, Rinaldi MG. Primary central nervous system phaeohyphomycosis: a review of 101 cases. Clin Infect Dis 2004; 38: 206–216.
43. Bejarano JIC, de Los Santos AM, Cisneros Saldana D, et al. Pediatric phaeohyphomycosis: A 44-Year systematic review of reported cases. J Pediatric Infect Dis Soc 2023; 12: 10–20.
44. Gulmez D. Ülkemizde nadir küf mantarlarına bağlı mikozlar: Sistematik bir derleme. Mikrobiyol Bul 2022; 56: 143–189.
45. Pastor FJ, Guarro J. Alternaria infections: laboratory diagnosis and relevant clinical features. Clin Microbiol Infect 2008; 14: 734–746.
46. Boyce RD, Deziel PJ, Otley CC, et al. Phaeohyphomycosis due to Alternaria species in transplant recipients. Transpl Infect Dis 2010; 12: 242–250.
47. Bhattaru A, Blanchard I, Kunamneni S, et al. Acrophialophora: A comprehensive review of clinical guidelines and diagnosis. Cureus 2023; 15: e37614.
48. Samaddar A, Sharma A, Shrimali T. Pulmonary infection due to Acrophialophora fusispora in a patient with underlying mixed connective tissue disease and chronic pulmonary aspergillosis:
A case report and review of literature. J Mycol Med 2020; 30: 100932.
49. Modlin CE, Collins LF, Burd EM, et al. Acrophialophora levis brain abscess in a kidney transplant patient: A case report and review of the literature. Med Mycol Case Rep 2020; 28: 12–15.
50. Santos DW, Padovan AC, Melo AS, et al. Molecular identification of melanised non-sporulating moulds: a useful tool for studying the epidemiology of phaeohyphomycosis. Mycopathologia
2013; 175: 445–454.
51. Pai HV, Jamal E, Yegneswaran PP. Corneal ulcer due to a rare pleosporalean member of the genus Bipolaris following cow tail injury to the eye: A case report and review of literature. Indian J
Ophthalmol 2017; 65: 403–405.
52. Badali H, Gueidan C, Najafzadeh MJ, et al. Biodiversity of the genus Cladophialophora. Stud Mycol 2008; 61: 175–191.
53. Jara-Ortega P, Ordonez-Apolo F, Jara-Ortega N, et al. Fungal infection by Cladophialophora bantiana and development of cerebral phaeohyphomycosis. A systematic review of 58 case reports.
Rev Neurol 2023; 77: 185–196.
54. da Cunha KC, Sutton DA, Fothergill AW, et al. In vitro antifungal susceptibility and molecular identity of 99 clinical isolates of the opportunistic fungal genus Curvularia. Diagn Microbiol
Infect Dis 2013; 76: 168–174.
55. Oner SZ, Kucukakin Yaka S, Akcaoglu T, et al. Curvularia lunata’ya bağlı gelişen fungal keratit: Türkiye’den ilk olgu raporu. Mikrobiyol Bul 2023; 57: 690–697.
56. Thitla T, Kumla J, Khuna S, et al. Species diversity, distribution, and phylogeny of Exophiala with the addition of four new species from Thailand. J Fungi (Basel) 2022; 8.
57. da Cunha KC, Sutton DA, Gene J, et al. Molecular identification and in vitro response to antifungal drugs of clinical isolates of Exserohilum. Antimicrob Agents Chemother 2012; 56: 4951–
4954.
58. Kauffman CA, Malani AN. Fungal infections associated with contaminated steroid injections. Microbiol Spectr 2016; 4.
59. Passero LFD, Cavallone IN, Belda W, Jr. Reviewing the etiologic agents, microbe-host relationship, immune response, diagnosis, and treatment in chromoblastomycosis. J Immunol Res 2021;
2021: 9742832.
60. Doymaz MZ, Seyithanoglu MF, Hakyemez I, et al. A case of cerebral phaeohyphomycosis caused by Fonsecaea monophora, a neurotropic dematiaceous fungus, and a review of the literature.
Mycoses 2015; 58: 187–192.
61. Kucukkaya IC, Gulsever CI, Dolas I, et al. First case of Rhinocladiella mackenziei brain abscess in Turkey: Case report and review of the literature. Mycoses 2023; 66: 755–766.
62. Al-Tawfiq JA, Boukhamseen A. Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei (formerly Ramichloridium mackenziei): case presentation and literature review. J Infect Public
Health 2011; 4: 96–102.
63. Al-Abdely HM, Alkhunaizi AM, Al-Tawfiq JA, et al. Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole. Med Mycol
2005; 43: 91–95.
64. Aldraihem M, Aldosary O, Almasaud WK, et al. Rhinocladiella mackenziei cerebral phaeohyphomycosis with a definitive outcome. BMJ Case Rep 2023; 16.
65. Al-Abdely HM, Najvar L, Bocanegra R, et al. SCH 56592, amphotericin B, or itraconazole therapy of experimental murine cerebral phaeohyphomycosis due to Ramichloridium obovoideum
(“Ramichloridium mackenziei”). Antimicrob Agents Chemother 2000; 44: 1159–1162.